Curing onychomycosis: Understanding the multitude of variables

Clinics in Podiatric Medicine and Surgery

Volumn 21, Issue 4, 2004, Pages 555-564

  Lagana, Frances J ^a,b  

^a Winchester Hospital   (United States)

^b Stoneham MA 02180 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; AMOROLFINE; ANTIFUNGAL AGENT; CICLOPIROX; CYCLOHEXIMIDE; CYTOCHROME P450; FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE; RIFAMPICIN; TERBINAFINE;

DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; HEALTH CARE; HEALTH CARE COST; HUMAN; IMMUNE RESPONSE; ONCHOCERCIASIS; PODIATRY; PRIORITY JOURNAL; REVIEW; TINEA PEDIS; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; FOOT DERMATOSES; HUMANS; ITRACONAZOLE; NAPHTHALENES; ONYCHOMYCOSIS;

EID: 4644371837     PISSN: 08918422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpm.2004.05.011     Document Type: Review

References (32)

1. VanderStraten M.R., Hossain M.A., Ghannoum M.A. Cutaneous infections dermatophytosis, onychomycosis and tinea versicolor. Infect Dis Clin N Am. 17:2003;87-112
2. Evans E.G.V. The rationale for combination therapy. Br J Dermatol. 145(Suppl 60):2001;9-13
3. Ghannoum M.A., Hajjeh R.A., Scher R., Konnikov N., Gupta A.K., Summerbell R., et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. Am Acad Dermatol. 43(4):2000;641-648
4. Scher R.K. Onychomycosis: a significant medical disorder. J Am Acad Dermatol. 35:1996;S2-S5
5. Lagana F. Nondermatophytes pathogen or distracter in onychomycosis. Clin Podiatr Med Surg. 12:1987;255-262
6. Baran R., Hay R.J., Tosti A., et al. A new classification of onychomycosis. Br J Dermatol. 139:1998;567-571
7. Salkin I.F., Padhye A.A., Kemna M.E. A new medium for the presumptive identification of dermatophytes. J Clin Microbiol. 35(10):1997;2660-2662
8. Borkowski P., Williams M., Holewinski J., Bakotic B. Onychomycosis: an analysis of 50 cases and a comparison of diagnostic techniques. J Am Pod Med Assoc. 91(7):2001;351-355
9. Gupta A.K., Ryder J.E., Summerbell R.C. The diagnosis of nondermatophytic mold onychomycosis. Int J Dermatol. 42:2003;272-273
10. Ellis D.H. Diagnosis of onychomycosis made simple. J Am Acad Dermatol. 40(6:2):1999;S3-S8
11. Gupta A.K., Cooper E.A., MacDonald P., Summerbell R.C. Utility of inoculum counting (Walshe and English criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi. J Clin Microbiol. 39(6):2001;2115-2121
12. Myskowski P.L., White M.H., Ahkami R. Fungal disease in the immunocompromised host. Derm Clin Infect Dis Dermatol. 15(2):1997;295-305
13. Botek G. Fungal nail infection: assessing the new treatment options. Cleve Clin J Med. 70(2):2003;110-118
14. Sigurgeirsson C.P., Curran D., Evans E.G.V. Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents. Br J Dermatol. 147:2002;1241-1243
15. Roberts D.T., Evans E.G.V. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol. 138:1998;189-190
16. Gupta A.K., Gupta M.A., Summerbell R.C., Cooper E.A., Konnikov N., Albreski D. The epidemiology of onychomycosis: possible roles of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol. 14:2000;466-469
17. Gupta A.K., Daniel C.R. III Factors that may affect the response of onychomycosis to oral antifungal therapy. J Dermatol. 39:1998;222-224
18. Farkas B., Paul C., Dobozy A., Hunyadi J., Horvath A., Fekete G. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin dependent diabetes mellitus: a muticentre trial. Br J Dermatol. 146:2002;254-260
19. Gupta A.K., Konnikov N., MacDonald P., Rich P., Roger N.W., Edmonds M.W., et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 139:1998;665-671
20. Zaias N., Tosti A., Rebell G., Morelli R., Bardazzi F., Bieley H., et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol. 34:1996;302-304
21. Macura A.B., Macura-Biegun A., Pawlik B. Susceptibility to fungal infections of nails in patients with primary antibody deficiency. CIMID. 26:2003;223-232
22. Elewski B.E. Onychomycosis treatment, quality of life, and economic issues. Am J Clin Dermatol. 1(1):2000;9-26
23. Leyden J. Pharmokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol. 38(5:3):1998;S42-S47
24. Heikkila H., Stubb S. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole. Br J Dermatol. 146:2002;250-253
25. Tosti A., Piraccini B.M., Stinchi C., Colombo M.D. Relapses of onychomycosis after successful treatment with systemic antifungals: a 3-year follow-up. Dermatology. 197:1998;162-166
26. Evans E.G.V. Causative pathogens in onychomycosis and the possibility of treatment resistance: a review. J Am Acad Dermatol. 38(5:3):1998;S32-S36
27. Pierard G.E., Pierard-Franchimont C., Arrese J.E. The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen. Dermatology. 200:2000;185-187
28. Baran R., Feuilhade M., Datry A., Goettmann S., Pietrini P., Viguie C., et al. A randomized trial of amoralfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycosis affecting the nail matrix region. Br J Dermatol. 142:2000;1177-1183
29. Gupta A.K., Ryder J.E., Baran R., Summerbell R.C. Non-dermatophytic onychomycosis. Dermatol Clin. 21:2003;257-268
30. Tosti A., Piraccini B.M., Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 42(2:1):2000;217-224
31. Tosti A., Piraccini B.M. Proximal subungual onychomycosis due to Aspergillus niger: report of 2 cases. Br J Dermatol. 139:1998;156-157
32. Harkless L.B., Dennis K.J. You see what you look for and recognize what you know. Clin Podiatr Med Surg. 4:1987;331-339